thrombectomy – Medxy AI

Timing Extubation After Thrombectomy: Evidence from the EDESTROKE Trial and Advanced Post-Reperfusion Management

By MedXY 04/05/2026

The EDESTROKE trial finds no significant difference in 90-day functional outcomes between early (<6h) and delayed (6-12h) extubation post-thrombectomy, shifting focus toward microvascular and hemodynamic optimization.

Neurology news Radiology

Beyond Recanalization: Understanding the Dynamic Evolution of the No-Reflow Phenomenon After Stroke Thrombectomy

By MedXY 03/10/2026

A prospective multicenter study reveals that the no-reflow phenomenon is a dynamic, evolving pathology following successful thrombectomy. It is significantly associated with infarct growth and poor functional outcomes, suggesting that achieving large vessel patency is only the first step in restoring cerebral perfusion.

Neurology news Radiology

Time-Dependent Topography: How Specific ASPECTS Regions Predict Outcomes in Early vs. Extended Window Large Vessel Occlusion Stroke

By MedXY 02/04/2026

A post-hoc analysis of 1,040 LVO stroke patients reveals that the prognostic value of specific brain regions varies significantly between early (0-6h) and extended (6-24h) time windows, identifying the insula, caudate, and M6 as early-window markers, and M3 and M5 as late-window predictors.

Neurology news

Long-Term Gains vs. Short-Term Risks: Decoding the Role of Bailout Angioplasty in Acute Large Vessel Occlusion

By MedXY 01/18/2026

The ANGEL-REBOOT trial reveals that while bailout angioplasty (BAOS) increases short-term procedural risks, it significantly improves one-year functional outcomes and reduces stroke recurrence in patients with failed thrombectomy or high-grade residual stenosis.

Neurology news Radiology

Emergent Carotid Stenting During Thrombectomy Superior for Tandem Lesion Stroke: Insights From the CERES-TANDEM Study

By MedXY 01/06/2026

The CERES-TANDEM study provides Class II evidence that emergent carotid stenting (eCAS) during endovascular thrombectomy for tandem lesions significantly improves 90-day functional outcomes without increasing hemorrhagic risk, supporting its integration into clinical practice for acute anterior circulation ischemic stroke.

Neurology news Radiology

Emergent Carotid Stenting Redefines Outcomes in Tandem Lesion Stroke: Insights from the CERES-TANDEM Study

By MedXY 01/06/2026

The multicenter CERES-TANDEM study provides Class II evidence that emergent carotid stenting (eCAS) during thrombectomy for tandem lesions significantly improves 90-day functional recovery without increasing the risk of symptomatic intracranial hemorrhage, offering a new benchmark for clinical practice.

Cardiology Critical Care news

The PERT Revolution: Rising Catheter-Directed Therapy Adoption Correlates with Improved Pulmonary Embolism Outcomes

By MedXY 01/02/2026

A multicenter registry study reveals that Pulmonary Embolism Response Teams (PERT) are increasingly utilizing catheter-directed therapies, particularly mechanical thrombectomy, leading to significantly lower in-hospital mortality and shorter hospital stays compared to national averages.

Neurology news Radiology

Endovascular Thrombectomy for Basilar Artery Occlusion: 3-Year Outcomes Confirm Durable Clinical Benefits

By MedXY 01/01/2026

Long-term data from the ATTENTION trial reveal that endovascular thrombectomy significantly improves functional outcomes and survival at three years for patients with basilar artery occlusion, establishing it as a durable standard of care.

Neurology news

Giving Thrombolysis Late — Before Transfer for Thrombectomy — May Improve Outcomes in AIS-LVO: Evidence from a 20-Center French Cohort

By MedXY 12/09/2025

A multicenter retrospective cohort found that IV thrombolysis started beyond 4.5 hours and before interhospital transfer for EVT was associated with higher rates of spontaneous recanalization during transfer and better 3‑month functional outcomes without increased hemorrhage.

Neurology news

Pretransfer IV Thrombolysis in Basilar Artery Occlusion: Improved Recanalization and 3‑Month Outcomes Without Clear Safety Signals

By MedXY 12/06/2025

In transferred patients with basilar artery occlusion (BAO), IV thrombolysis before transfer was associated with higher rates of basilar recanalization and better 3‑month functional outcomes, with no significant increase in mortality or 24‑hour intracerebral hemorrhage.

Neurology news

Giving IV Thrombolysis in the Late Window Before Transfer for Thrombectomy: Improved Recanalization and 3‑Month Outcomes in a Multicenter French Cohort

By MedXY 12/06/2025

A multicenter retrospective cohort (OPEN-WINDOW) found that IV thrombolysis given beyond 4.5 hours before interhospital transfer for EVT was associated with higher rates of recanalization during transfer and better 3‑month functional outcomes without increased hemorrhagic complications.

Clinical Updates Neurology news

Intravenous Antihypertensives Post-Endovascular Thrombectomy: Implications for Functional Recovery in Acute Ischemic Stroke

By MedXY 09/19/2025

Intravenous antihypertensive use within 24 hours after successful EVT in acute ischemic stroke associates with poorer functional outcomes and higher mortality, underscoring the need for cautious blood pressure management strategies post-thrombectomy.

Clinical Updates Neurology Specialties

Optimizing Head Positioning in Large Vessel Occlusion Stroke Before Thrombectomy: Evidence from a Randomized Clinical Trial

By MedXY 09/11/2025

A recent randomized clinical trial demonstrates that 0° head-of-bed positioning prior to thrombectomy in patients with large vessel occlusion stroke preserves neurological stability and reduces mortality compared to the conventional 30° elevation.

Neurology news Specialties

Thrombolysis Before Thrombectomy May Raise ICH Risk After Stroke: A Comprehensive Review of Recent Evidence

By MedXY 08/19/2025

A meta-analysis of over 2000 stroke patients found that intravenous thrombolysis (IVT) before endovascular treatment (EVT) modestly increases intracranial hemorrhage (ICH) risk, especially in patients with elevated glucose and blood pressure, though functional benefits may still outweigh risks.

Neurology Specialties

Unexplained Early Neurologic Deterioration After Thrombectomy in Stroke: Incidence, Risk Factors, and Mechanistic Insights

By MedXY 08/17/2025

Unexplained early neurologic deterioration (unEND) affects about 10% of ischemic stroke patients after thrombectomy, linked to age, anesthesia, delayed reperfusion, and infarct growth beyond hypoperfused tissue.

Neurology Specialties

Tenecteplase in Modern Stroke Care: Comparative Insights from Recent Chinese Clinical Trials

By MedXY 08/01/2025

Three major Chinese trials examine intravenous and intra-arterial tenecteplase as adjuncts to thrombectomy in acute large-vessel occlusion stroke, revealing functional benefit with intravenous use before thrombectomy but not after reperfusion.

Clinical Updates Neurology news Specialties

Intra-arterial Tenecteplase After Thrombectomy for Acute Stroke: Interpreting the ANGEL-TNK Randomized Clinical Trial

By MedXY 07/31/2025

The ANGEL-TNK trial found that intra-arterial tenecteplase after successful endovascular thrombectomy improved excellent neurological outcomes at 90 days without increasing bleeding or mortality, but secondary outcomes showed no significant benefit.

Clinical Updates news

Intra-arterial Tenecteplase After Thrombectomy for Acute Stroke: Interpreting the ANGEL-TNK Randomized Clinical Trial

By MedXY 07/31/2025